Purus Wealth Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
WT
NONA
SIM
OIAM
FFM
NO
Purus Wealth Management's EW Position: Q2 2026 in Review
Purus Wealth Management reduced its Edwards Lifesciences (EW) stake by 11% in Q2 2026, selling an estimated $30.7K and leaving 2,885 shares worth $261K. The position accounts for 0.07% of the portfolio, ranked #144.
Purus Wealth Management first reported a position in EW in Q4 2021 and has held it in 19 quarters since. The position peaked at $342K in Q1 2022. 195 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Purus Wealth Management held 2,885 shares of Edwards Lifesciences worth $261K as of Q2 2026.
- Purus Wealth Management sold 367 Edwards Lifesciences shares in Q2 2026, an estimated $30.7K.
- Edwards Lifesciences made up 0.07% of Purus Wealth Management's portfolio in Q2 2026, its #144 holding.
- Purus Wealth Management first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 19 quarters since.
- Purus Wealth Management's Edwards Lifesciences position peaked at $342K in Q1 2022.
- 195 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Purus Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.